DOI: 10.12890/2020_001526
Blue Woman Syndrome and Thyrotoxicosis in a Patient on Amiodarone
Authors
-
Radovan Hojs
-
Tadej Pedreski
Department of Nephrology, 4th Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia
-
Nejc Piko
Department of Nephrology, 4th Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia
-
Matevž Privšek
Centre for Emergency Medicine, University Medical Centre Maribor, Maribor, Slovenia
-
Tadej Zorman
Centre for Emergency Medicine, University Medical Centre Maribor, Maribor, Slovenia
-
Sebastjan Bevc
Department of Nephrology, 4th Department of Dialysis, Clinic for Internal Medicine, University Medical Centre Maribor, Maribor, Slovenia
tadej.petreski@ukc-mb.si
Keywords
Amiodarone, adverse drug reaction, hyperthyroidism, atrial fibrillation, skin pigmentation
Abstract
Amiodarone is an antiarrhythmic drug, in use from the 1960s, which acts on potassium transport in myocytes, causing a lengthening of the action potential and refractory period. Even though it is broadly prescribed, its use is limited by a relatively high occurrence of adverse reactions such as lung, thyroid or hepatic disease, skin changes and so on. The authors report a case of a female patient who was admitted due to chest pain. Due to the bluish skin pigmentation, other causes of amiodarone toxicity were investigated, and hyperthyroidism was detected. After amiodarone discontinuation and specific therapy, thyroid function returned to normal.
View the entire article
Downloads
How to Cite
1.
Hojs R, Pedreski T, Piko N, Privšek M, Zorman T, Bevc S. Blue Woman Syndrome and Thyrotoxicosis in a Patient on Amiodarone. EJCRIM [Internet]. 2020 Mar. 3 [cited 2026 Nov. 18];7(4). Available from:
https://ojs.wedare.app/ejcrim/article/view/1526